The University of Texas MD Anderson Cancer Center, Department of Leukemia, Division of Cancer Medicine is a clinical research site located in Houston, Texas, United States 77030.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
The University of Texas MD Anderson Cancer Center, Department of Leukemia, Division of Cancer Medicine has participated in 1 clinical trials.
Therapeutic areas: Acute Myeloid Leukaemia (AML), Myelodysplastic Syndrome (MDS).
Sponsors: Institut de Recherches Internationales Servier.
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
The University of Texas MD Anderson Cancer Center, Department of Leukemia, Division of Cancer Medicine has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The University of Texas MD Anderson Cancer Center, Department of Leukemia, Division of Cancer Medicine has 1 clinical trials on record. Their work covers Acute Myeloid Leukaemia (AML), Myelodysplastic Syndrome (MDS).
The University of Texas MD Anderson Cancer Center, Department of Leukemia, Division of Cancer Medicine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.